Research map: Corticosteroid Therapy for Drug-induced Liver Injury: Mind the Gap!
Back to the article
Papers in this map
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update
· Bryan J. Schneider · 2021 · 2223 citations · Cited by this paper
Quantitative Bias Analysis of Unmeasured Confounding Refines Interpretation of Longitudinal Associations Between Cardiometabolic Risk Factors and Liver Stiffness in MASLD
· 2026 · Related
Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
· John B.A.G. Haanen · 2022 · 1289 citations · Cited by this paper
Updates in clinical science: Alcohol-related hepatitis
· 2026 · Related
Case Definition and Phenotype Standardization in Drug-Induced Liver Injury
· Guruprasad Padur Aithal · 2011 · 1042 citations · Cited by this paper
Low-dose bevacizumab plus atezolizumab enhances transarterial chemoembolization in HCC via correcting vascular-immune niche dysfunction
· 2026 · Related
EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure
· Julia Alexis Wendon · 2017 · 1022 citations · Cited by this paper
OSM-STAT3 signaling facilitates Long-term expansion of Pediatric Hepatic Organoids
· 2026 · Related
Glucocorticoid resistance in inflammatory diseases
· Peter John Barnes · 2009 · 987 citations · Cited by this paper
JHEP at a glance (August 2026)
· 2026 · Related
How corticosteroids control inflammation: Quintiles Prize Lecture 2005
· Peter John Barnes · 2006 · 841 citations · Cited by this paper
Before repurposing Fusobacterium nucleatum in alcohol-associated liver disease: it is a rare, non-resident organism in the human alcoholic gut
· 2026 · Related
Non-genomic Effects of Glucocorticoids: An Updated View
· Reynold A. Panettieri · 2018 · 294 citations · Cited by this paper
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort
· 2026 · Related
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
· Robert J. Fontana · 2022 · 293 citations · Cited by this paper
Non-selective β-blockers reduce bacterial translocation by restoring gut barrier function during experimental cirrhosis
· 2026 · Related
Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice
· Xiaogang Xiang · 2019 · 201 citations · Cited by this paper
Metabolic dysfunction profiles identify heterogeneous hepatocellular carcinoma risk in MASLD-associated advanced fibrosis
· 2026 · Related
Steroid Use in Acute Liver Failure
· Jamuna Karkhanis · 2013 · 199 citations · Cited by this paper
Revisiting rejection after immune checkpoint inhibitor exposure prior to liver transplantation for hepatocellular carcinoma
· 2026 · Related
Early Use of High-Dose Glucocorticoid for the Management of irAE Is Associated with Poorer Survival in Patients with Advanced Melanoma Treated with Anti–PD-1 Monotherapy
· Xue Li Bai · 2021 · 186 citations · Cited by this paper
Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting report
· Raúl J. Andrade · 2023 · 160 citations · Cited by this paper
A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury
· Elizabeth T. Cirulli · 2019 · 138 citations · Cited by this paper
Death and liver transplantation within 2 years of onset of drug‐induced liver injury
· Paul Hideyo Hayashi · 2017 · 133 citations · Cited by this paper
Glucocorticoids Shape Macrophage Phenotype for Tissue Repair
· Thibaut Desgeorges · 2019 · 105 citations · Cited by this paper
Steroid and Ursodesoxycholic Acid Combination Therapy in Severe Drug-Induced Liver Injury
· Alexander Wree · 2011 · 104 citations · Cited by this paper
Immune-related hepatitis with immunotherapy: Are corticosteroids always needed?
· Marie-Léa Gauci · 2018 · 97 citations · Cited by this paper
Clinical Characteristics and Adverse Impact of Hepatotoxicity due to Immune Checkpoint Inhibitors
· Ethan Miller · 2019 · 96 citations · Cited by this paper
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune Hepatitis
· Simon Pape · 2019 · 90 citations · Cited by this paper
Drug-Induced Liver Injury: Highlights and Controversies in the Recent Literature
· Joseph William Clinton · 2021 · 88 citations · Cited by this paper
Liver biopsy findings in patients on immune checkpoint inhibitors
· Justine Vanessa Cohen · 2020 · 86 citations · Cited by this paper
Pharmacogenomics of drug-induced liver injury (DILI): Molecular biology to clinical applications
· Kalaiyarasi Kaliyaperumal · 2018 · 82 citations · Cited by this paper
Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatment
· Helgi Kristinn Björnsson · 2021 · 74 citations · Cited by this paper
Effect of corticosteroid dosing on outcomes in high‐grade immune checkpoint inhibitor hepatitis
· Michael Li · 2021 · 72 citations · Cited by this paper
A new framework for advancing in drug‐induced liver injury research. The Prospective European DILI Registry
· Einar Stefan Bjornsson · 2022 · 71 citations · Cited by this paper
Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report
· Helen Marie McGuire · 2017 · 65 citations · Cited by this paper
Beneficial effect of corticosteroids for patients with severe drug‐induced liver injury
· Ping Fang Hu · 2016 · 54 citations · Cited by this paper
Survival Among Veterans Receiving Steroids for Immune-Related Adverse Events After Immune Checkpoint Inhibitor Therapy
· Inga Van Buren · 2023 · 54 citations · Cited by this paper
Identification of Reduced ERAP2 Expression and a Novel HLA Allele as Components of a Risk Score for Susceptibility to Liver Injury Due to Amoxicillin-Clavulanate
· Paola Nicoletti · 2022 · 49 citations · Cited by this paper
Source: OpenAlex (CC0)